Burden of Parkinson's disease from 1990 to 2021 at the global, regional, and national level, with forecasts to 2035 [0.03%]
1990至2021年全球、区域和国家层面帕金森病疾病负担及2035年预测
Sibo Huang,Jialin Wu,Gerun Chen et al.
Sibo Huang et al.
Background: Parkinson's disease (PD) poses a growing global health challenge. Our study systematically assessed the global, regional, and national burden of PD from 1990 to 2021 and projected trends to 2035. ...
Multivariate analysis of sex differences in Parkinson's disease: the distinct contributions of fall-related self-efficacy and voice handicap [0.03%]
帕金森病的多变量分析：与跌倒相关的自我效能感和声音受损对性别差异的特殊贡献
Halil Onder,Zehra Yavuz,Sevim Kapukaya et al.
Halil Onder et al.
Background: Sex-related differences in Parkinson's disease (PD) have been frequently reported, yet most studies are descriptive and do not account for confounders. Identifying independent predictors may clarify sex-linked...
"What about me? I'm supposed to be … superhuman?": exploring staff perspectives on how to deliver high quality psychological care for people living with amyotrophic lateral sclerosis [0.03%]
“那我呢？我是超级人类吗？”——探索高水平心理护理在ALS患者身上的应用：工作人员视角
Sarah Creer,Alys Wyn Griffiths,Esther Hobson et al.
Sarah Creer et al.
Objectives: To explore healthcare professionals' experiences of providing informal psychological care in Amyotrophic Lateral Sclerosis (ALS) services. Met...
Patient and caregiver attitudes to cognitive and behavioral testing in Amyotrophic Lateral Sclerosis [0.03%]
ALS患者和护理人员对认知和行为评估的态度
Leslie Ing,Alys Wyn Griffiths,Emily Mayberry et al.
Leslie Ing et al.
Background: Cognitive and behavioral changes affect up to 50% of people with Amyotrophic Lateral Sclerosis (ALS) and are associated with worse outcomes, yet remain under-recognized in clinical care. Understanding patient ...
Punding in dementia: an insight into its occurrence, clinical characteristics, treatment, and outcome [0.03%]
痴呆症中的自动症：对其发生、临床特征、治疗和预后的洞察
Shailendra Mohan Tripathi,Porimita Chutia,Mohit Kumar Shahi et al.
Shailendra Mohan Tripathi et al.
Aim: This study investigates punding in dementia, its characteristics, treatment options, and outcomes. Methods: In this retrospective ...
Daniel Hill,Kun Pei,Maria Francesca Cordeiro
Daniel Hill
The therapeutic potential of laquinimod for Huntington's disease: A systematic review of preclinical and clinical studies [0.03%]
拉喹莫德治疗亨廷顿舞蹈病的潜力：系统性回顾预临床和临床研究
Negin Eissazade,Hesam Mosavari,Dina Hemmati et al.
Negin Eissazade et al.
Introduction: Neuroinflammation is a central contributor to Huntington's disease (HD) pathogenesis and represents a promising therapeutic target. Laquinimod, an oral immunomodulator with demonstrated neuroprotective effec...
An implementation study of a remote monitoring platform to increase access to specialist care in motor neuron disease [0.03%]
关于远程监控平台的实施研究增加肌萎缩侧索硬化专病医疗的途径
Liam Knox,Polly Kennedy,Deirdre Gilsenan et al.
Liam Knox et al.
Introduction: The aim was to examine the engagement and acceptability of Telehealth in MND (TiM) as part of usual care within two specialist centers. Meth...
Brexpiprazole for treating agitation in different groups of people with Alzheimer's dementia: a plain language summary [0.03%]
老年痴呆患者激越的布瑞哌唑治疗：不同人群中的疗效总结
Jared Stroud,Jeffrey L Cummings,Sanjeda R Chumki et al.
Jared Stroud et al.
Brain aging in neurodevelopmental disorders: a narrative review of oxidative, inflammatory, and mitochondrial mechanisms [0.03%]
神经发育障碍中的脑衰老：氧化、炎症和线粒体机制的叙述性综述
Maiara de Aguiar da Costa,Victória Linden de Rezende,Sofia Januário Bolan et al.
Maiara de Aguiar da Costa et al.
Neurodevelopmental disorders (NDDs), including autism spectrum disorder, attention deficit/hyperactivity disorder, intellectual disability, and Down syndrome, are increasingly examined through the lens of aging. Emerging evidence indicates ...